Cargando…

Clinical features of nursing and healthcare-associated pneumonia due to COVID-19

INTRODUCTION: The objective of this study was to clarify the clinical differences between nursing and healthcare-associated pneumonia (NHCAP) and community-acquired pneumonia (CAP) due to COVID-19. We also investigated the clinical characteristics to determine whether there is a difference between t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyashita, Naoyuki, Nakamori, Yasushi, Ogata, Makoto, Fukuda, Naoki, Yamura, Akihisa, Ishiura, Yoshihisa, Nomura, Shosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934135/ https://www.ncbi.nlm.nih.gov/pubmed/35317976 http://dx.doi.org/10.1016/j.jiac.2022.03.010

Ejemplares similares

Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19
por: Miyashita, Naoyuki, et al.
Publicado: (2023)

Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findings
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

A warning related to predicting the severity of COVID-19 pneumonia using the A-DROP scoring system
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Prognosis of activities of daily living function in hospitalized patients with nursing and healthcare‐associated pneumonia due to COVID‐19
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections
por: Miyashita, Naoyuki, et al.
Publicado: (2023)

Functional outcomes in elderly patients with hospitalized COVID‐19 pneumonia: A 1 year follow‐up study
por: Miyashita, Naoyuki, et al.
Publicado: (2022)

Efficacy of gefapixant, a P2X(3) antagonist, for lung cancer-related cough: a case report
por: Ishiura, Yoshihisa, et al.
Publicado: (2023)

Efficacy of Gefapixant, a P2X(3) Antagonist, for Refractory Atopic Cough
por: Ishiura, Yoshihisa, et al.
Publicado: (2023)

Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study
por: Ishiura, Yoshihisa, et al.
Publicado: (2022)

Atypical pneumonia due to SARS-CoV-2: Clinical differentiation using the JRS pneumonia guidelines
por: Miyashita, Naoyuki
Publicado: (2022)

A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis
por: Ishii, Nobuyasu, et al.
Publicado: (2021)

Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation
por: Nomura, Shosaku, et al.
Publicado: (2023)

Spatial and temporal genetic heterogeneity of epidermal growth factor receptor gene status in a patient with non-small cell lung cancer: a case report
por: Ogata, Makoto, et al.
Publicado: (2011)

Effect of triple therapy in patients with asthma-COPD overlap
por: Ishiura, Yoshihisa, et al.
Publicado: (2019)

Localized lymphadenopathy with myelodysplastic syndrome associated with tuberculosis
por: Nakaya, Aya, et al.
Publicado: (2019)

Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing
por: Miyashita, Naoyuki, et al.
Publicado: (2009)

Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap
por: Ishiura, Yoshihisa, et al.
Publicado: (2020)

Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy
por: KIBATA, KAYOKO, et al.
Publicado: (2013)

Immunological Features of Pediatric Interstitial Pneumonia Due to Mycoplasma pneumoniae
por: Xu, Xuefeng, et al.
Publicado: (2021)

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer
por: Niki, Maiko, et al.
Publicado: (2018)

Retrospective analysis of bevacizumab‐induced hypertension and clinical outcome in patients with colorectal cancer and lung cancer
por: Nakaya, Aya, et al.
Publicado: (2016)

Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literature
por: INAGAKI, NORIKO, et al.
Publicado: (2013)

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

Clinical Features and Risk Factors for Mortality in Hospitalized Older Adults with Pneumonia
por: Fukuda, Nobuhiko, et al.
Publicado: (2021)

Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports
por: Okamori, Satoshi, et al.
Publicado: (2020)

Advances in Diagnosis and Treatments for Immune Thrombocytopenia
por: Nomura, Shosaku
Publicado: (2016)

Chlamydia pneumoniae and Exacerbations of Asthma in Adults
por: Miyashita, Naoyuki, et al.
Publicado: (1998)

Ecological Risks Due to Immunotoxicological Effects on Aquatic Organisms
por: Kataoka, Chisato, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
por: Nakaya, Aya, et al.
Publicado: (2018)

Increased Accessibility to Primary Healthcare Due to Nurse Prescribing of Medicines
por: Kilańska, Dorota, et al.
Publicado: (2021)

Healthcare-associated Pneumonia: Clinical Features and Retrospective Analysis Over 10 Years
por: Qi, Fei, et al.
Publicado: (2015)

Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients
por: Sawai, Yusuke, et al.
Publicado: (2020)

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer
por: Nakatani, Yuki, et al.
Publicado: (2017)

Phase I/II study of erlotinib, carboplatin, pemetrexed, and bevacizumab in chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer harboring epidermal growth factor receptor mutation
por: Kurata, Takayasu, et al.
Publicado: (2017)

Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis
por: Reynolds, Courtney A, et al.
Publicado: (2014)

Treatment of Connective Tissue Disease-Related Intractable Disease with Biological Therapeutics
por: Ozaki, Yoshio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_loon7humtgf8rbt2mui76vi3a0